US Stock MarketDetailed Quotes
UNCY Unicycive Therapeutics
- 0.3179
- -0.0199-5.89%
Close Sep 3 16:00 ET
- 0.3299
- +0.0120+3.77%
Post 19:59 ET
30.00MMarket Cap-883P/E (TTM)
0.3512High0.3100Low3.70MVolume0.3326Open0.3378Pre Close1.26MTurnover4.62%Turnover RatioLossP/E (Static)94.36MShares1.818052wk High-2.02P/B25.43MFloat Cap0.202052wk Low--Dividend TTM79.98MShs Float8.7300Historical High--Div YieldTTM12.20%Amplitude0.2020Historical Low0.3400Avg Price1Lot Size
Unicycive Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -14.85%-6.32M | -64.69%-6.46M | -16.82%-18.28M | 27.04%-4.44M | -24.11%-4.42M | -80.57%-5.5M | -32.57%-3.92M | -171.39%-15.65M | -333.64%-6.08M | -2.56%-3.56M |
| Net income from continuing operations | 356.77%9.86M | -43.83%-20.96M | -69.14%-30.54M | -46.36%-7.8M | 22.03%-4.33M | -5.56%-3.84M | -312.07%-14.58M | -80.27%-18.06M | -93.60%-5.33M | -6.84%-5.56M |
| Operating gains losses | -5,860.99%-16.81M | 13.81%11.81M | --10.3M | --1.61M | ---1.4M | ---282K | --10.38M | ---- | ---- | ---- |
| Depreciation and amortization | -244.87%-113K | 531.11%284K | 76.40%284K | 95.24%82K | 97.50%79K | 95.00%78K | 15.38%45K | 1,138.46%161K | 223.08%42K | --40K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.35%21K | ---- | ---- |
| Change In working capital | 106.73%108K | 1,980.22%1.89M | -107.89%-93K | 210.33%1.12M | -82.29%299K | -729.02%-1.6M | -63.75%91K | 1,221.90%1.18M | -184.11%-1.02M | 231.98%1.69M |
| -Change in prepaid assets | 132.91%365K | 297.63%1.34M | -1,901.61%-1.12M | 328.96%767K | -388.16%-1.11M | -406.35%-1.11M | 28.52%338K | 104.68%62K | -175.79%-335K | 86.76%-228K |
| -Change in payables and accrued expense | 15.84%-372K | 525.91%822K | 0.71%1.28M | 166.61%427K | -24.05%1.48M | -531.43%-442K | -904.17%-193K | 2.84%1.27M | -182.39%-641K | 341.08%1.95M |
| -Change in other current liabilities | 316.98%115K | -405.56%-273K | -66.89%-252K | -82.50%-73K | -89.47%-72K | -43.24%-53K | -50.00%-54K | -1,158.33%-151K | -233.33%-40K | ---38K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -14.85%-6.32M | -64.69%-6.46M | -16.82%-18.28M | 27.04%-4.44M | -24.11%-4.42M | -80.57%-5.5M | -32.57%-3.92M | -171.39%-15.65M | -333.64%-6.08M | -2.56%-3.56M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -66.67%-20K | -6K | -500.00%-12K | 0 | 0 | -12K | 0 | 93.10%-2K | 0 | 0 |
| Net PPE purchase and sale | -66.67%-20K | ---6K | -500.00%-12K | --0 | --0 | ---12K | --0 | 93.10%-2K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -66.67%-20K | ---6K | -500.00%-12K | --0 | --0 | ---12K | --0 | 93.10%-2K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -811K | 64.37%45.69M | 5,947.35%27.54M | 56.48%-205K | -51K | 0 | 27.8M | -102.11%-471K | -471K | 0 |
| Net common stock issuance | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -99.95%11K | ---- | ---- |
| Net preferred stock issuance | --0 | 65.62%50M | --30.19M | --0 | --0 | --0 | --30.19M | --0 | --0 | --0 |
| Net other financing activities | --284K | -80.07%-4.31M | -449.59%-2.65M | ---205K | ---51K | --0 | ---2.39M | ---482K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---811K | 64.37%45.69M | 5,947.35%27.54M | 56.48%-205K | ---51K | --0 | --27.8M | -102.11%-471K | ---471K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 101.09%48.93M | 2,032.09%9.7M | -97.26%455K | 104.64%14.35M | 77.98%18.82M | 78.65%24.33M | -97.26%455K | --16.58M | -61.08%7.01M | 1,057,200.00%10.57M |
| Current changes in cash | -29.67%-7.15M | 64.30%39.23M | 157.34%9.25M | 29.15%-4.64M | -25.54%-4.47M | -80.96%-5.51M | 906.93%23.88M | -197.26%-16.12M | -357.75%-6.56M | -119.78%-3.56M |
| End cash Position | 122.02%41.78M | 101.09%48.93M | 2,032.09%9.7M | 2,032.09%9.7M | 104.64%14.35M | 77.98%18.82M | 78.65%24.33M | -97.26%455K | -97.26%455K | -61.08%7.01M |
| Free cash flow | -14.96%-6.34M | -64.85%-6.46M | -16.88%-18.3M | 27.04%-4.44M | -24.11%-4.42M | -80.96%-5.51M | -32.48%-3.92M | -170.07%-15.65M | -324.86%-6.08M | -2.56%-3.56M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg